Memorial Sloan Kettering Cancer Center to Build Inpatient Pavilion

Memorial Sloan Kettering Cancer Center (MSK) will construct the Kenneth C. Griffin Pavilion in New York to revolutionize the prevention, diagnosis, and treatment of cancer. Shaped by the architectural vision of CannonDesign in association with Foster + Partners, the $2.3 billion facility will provide 208 single-occupancy inpatient beds and 12 enhanced operating and procedure suites. Integrating leading-edge robotics and digital infrastructure, the 27-story structure will significantly expand capacity to meet a growing need for care, while also accommodating more complex cases. 

Spanning 883,000 sf, the patient-centered building will connect to MSK’s existing hospital on its main Manhattan campus via an enclosed two-story patient bridge. Flexible spaces will enable the incorporation of advanced technologies and machinery in the future, and a modular and standardized layout will promote ease of navigation. The development will be built by a joint venture of Turner Construction Company and Consigli Construction Co., Inc. The project team also includes AvroKO, Studio O+A, and MNLA. Structural demolition and excavation work began on site in 2025 and steel erection will start in mid-2027. Completion is expected in mid-2030.